CancerIQ is a venture-backed digital health company that helps providers use genetic information to predict, pre-empt, and prevent disease – starting with cancer. Through our workflow automation and artificial intelligence - we make it faster, cheaper, and more profitable for providers to integrate genetics into routine care. We market our solutions nationwide to cancer centers, breast centers and genetics practices, and have delivered value to over 140 clinics across the country.
Position and Responsibilities
We are looking for someone who knows what it takes to build and iterate on a sales process, who treats the “job” as his or her own business, and thrives on learning about new innovations in the genetics and genomics space. Prior experience selling in the healthcare space is strongly preferred, as well as someone who is driven to surpass goals while delivering a great experience to prospects, clients and coworkers. In addition to these qualities, we are looking for the following:
Note: At CancerIQ, the safety and wellness of our employees is our top priority. To provide our employees with the support they may need to maintain their personal health and wellness, our office is open and available for those employees who are interested in using it. Our long-term goal is for CancerIQ employees to return to our Chicago office, however working remotely will be an option until everyone is comfortable, and it is 100% safe for all to return.
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status
CancerIQ requires you are authorized to work in the U.S. as a precondition of employment. We are unable to grant sponsorships at this time.
CancerIQ (http://canceriq.com) is a venture-backed digital health company that uses predictive analytics to help doctors understand their patient's risk of getting cancer and dying from cancer. By making it easier and cheaper for providers to deliver cancer genetic risk assessment services, ...